Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)
| 0.6112 Delayed Data As of Jul 01 |  -0.0388 / -5.97%Today’s Change | 0.42 Today|||52-Week Range 3.42 | -66.42% Year-to-Date |
Latest GLMD News | Press Releases
No recent news for Galmed Pharmaceuticals Ltd.
Today’s Trading
| Previous close | 0.65 |
| Today’s open | 0.61 |
| Day’s range | 0.61 - 0.61 |
| Volume | 204 |
| Average volume (3 months) | 96,255 |
| Market cap | $12.1M |
Data as of 10:03am ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -94,178.57% |
| Earnings growth (this year) | +29.09% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.40 |
Competitors
| ---- | ||
| PULMPulmatrix Inc | 0.00 | 0.00% |
| BBIBrickell Biotech Inc | -0.03 | -22.38% |
| NERVMinerva Neuroscience... | +0.39 | +11.78% |
Data as of 4:03pm ET, 07/01/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$32.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tel Aviv, Tel Aviv |
Forecasts
